UROLOGY, cilt.53, sa.2, ss.381-385, 1999 (SCI-Expanded, Scopus)
Objectives. To investigate whether the frequency of chromosome abnormalities in peripheral blood lymphocytes defined as the aneuploidy index in blood (AnIB) can be used as a clinical marker of early age onset, androgen response, and metastasis in human prostate cancer.